NCT00000262View on ClinicalTrials.gov

Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 1996

Primary Completion Date

February 28, 1999

Study Completion Date

February 28, 1999

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

30% Nitrous oxide

DRUG

0.4% Sevoflurane

DRUG

0.2% sevoflurane

OTHER

Placebo

Trial Locations (1)

60637

University of Chicago, Anesthesia & Critical Care, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT00000262 - Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 | Biotech Hunter | Biotech Hunter